SAGE THERAPEUTICS, INC.
|SAGE THERAPEUTICS, INC. Patent applications|
|Patent application number||Title||Published|
|20160108080||19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF - Provided herein are 19-nor C3,3-disubstituted C21-pyrazolyl steroids of Formula (I), and pharmaceutically acceptable salts thereof; wherein-, R||04-21-2016|
|20160083417||19-NOR C3, 3-DISUBSTITUTED C21-C-BOUND HETEROARYL STEROIDS AND METHODS OF USE THEREOF - Provided herein are 19-nor C3,3-disubstituted steroids of Formula (I): and pharmaceutically acceptable salts thereof; wherein,||03-24-2016|
|20150291654||3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF - Provided herein are 3,3-disubstituted 19-nor-steroidal compounds according to Formula (I) and (III): where R||10-15-2015|
|20150175651||NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF - Described herein are neuroactive steroids of the Formula (1) or a pharmaceutically acceptable salt, solvate, stereoisomer, tautomer, and/or isotopic variant thereof. Such compounds are envisioned, in certain embodiments, to behave as soft drugs and, in certain embodiments, as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.||06-25-2015|
|20150158903||NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF - Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, wherein Z is a group of the formula (i), (ii), (iii), (iv), or (v), and wherein L||06-11-2015|
|20140057885||METHODS OF TREATING EPILEPSY OR STATUS EPILEPTICUS - Described herein are methods of treating epilepsy or status epilepticus, e.g., convulsive status epilepticus, e.g., early status epilepticus, established status epilepticus, refractory status epilepticus, super-refractory status epilepticus, e.g., super-refractory generalized status epilepticus; non-convulsive status epilepticus, e.g., generalized status epilepticus, complex partial status epilepticus; generalized periodic epileptiform discharges; periodic lateralized epileptiform discharges; a seizure, e.g., acute repetitive seizures, cluster seizures, the method comprising administering to the subject a neuroactive steroid.||02-27-2014|
Patent applications by SAGE THERAPEUTICS, INC.